Calendar of events for Postal Ballot
Bafna Pharmaceuticals Ltd has submitted to BSE a copy of Calendar of events for Postal Ballot.11-01-2017
Calendar of events for Postal Ballot
Bafna Pharmaceuticals Ltd has submitted to BSE a copy of Calendar of events for Postal Ballot.Notice of Postal Ballot
Bafna Pharmaceuticals Ltd has submitted to BSE a Copy of the Notice of Postal Ballot.Updates
Bafna Pharmaceuticals Ltd has informed BSE regarding "Disclosure of material event under Regulation 30(2) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015".Outcome of Board Meeting
Bafna Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company was held on January 07, 2017 and the said meeting commenced at 12.00 P.M. and concluded at 01.45 P.M.In the meeting, the following matters were decided by the Board:Considered and decided to issue 80,00,000 share warrants on preferential basis to promoter and non-promoter group at such price as may be arrived at in accordance with SEBI...Updates on Outcome of Board Meeting
Bafna Pharmaceuticals Ltd has informed BSE that meeting of the Board of Directors of the Company was held on January 04, 2017, where it was decided to withdraw entire preferential issue of 40,00,000 share warrants and in-principle application filed with the Stock Exchanges.Outcome of Board Meeting
Bafna Pharmaceuticals Ltd has informed BSE about Outcome of Board Meeting held on January 04, 2017.Bafna Pharma: preference issue in focus
The board of Bafna Pharmaceuticals plans to withdraw the entire preferential issue of 40 lakh share warrants as one of the investors is ineligible to be involved in share dealings within the group...Board Meeting on Jan 04, 2017
Bafna Pharmaceuticals Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled to be held on January 04, 2017, to transact following business:1. Withdrawal of entire preferential issue of 40,00,000 share warrants and in-principle application filed with the Stock Exchanges due to the following reasons:...Updates
Bafna Pharmaceuticals Ltd has submitted to BSE a copy of brief profile of Sapna Jain.